Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts.
Beauverd Y, Morin S, Nabergoj M, Stephan C, De Ramon Ortiz C, Mamez AC, Mahne E, Petropoulou A, Giannotti F, Ayer C, Bruno B, Bounaix L, Anastasiou M, Mappoura M, Tran TA, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: mappoura m. Transplant Cell Ther. 2021 Jan;27(1):67.e1-67.e7. doi: 10.1016/j.bbmt.2020.09.022. Epub 2020 Sep 24. Transplant Cell Ther. 2021. PMID: 32980547 Free article.
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
Beauverd Y, Morin S, Stephan C, De Ramon Ortiz C, Fabra Urdiola M, Giannotti F, Mahne E, Mamez AC, Mappoura M, Simonetta F, Tran TA, Ayer C, Noetzlin S, Verdon I, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: mappoura m. Bone Marrow Transplant. 2021 Sep;56(9):2284-2286. doi: 10.1038/s41409-021-01334-6. Epub 2021 May 18. Bone Marrow Transplant. 2021. PMID: 34007052 No abstract available.
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Chalandon Y, Mamez AC, Giannotti F, Beauverd Y, Dantin C, Mahne E, Mappoura M, Bernard F, de Ramon Ortiz C, Stephan C, Morin S, Ansari M, Simonetta F, Masouridi-Levrat S. Chalandon Y, et al. Among authors: mappoura m. Transplant Cell Ther. 2022 Nov;28(11):765.e1-765.e9. doi: 10.1016/j.jtct.2022.08.003. Epub 2022 Aug 8. Transplant Cell Ther. 2022. PMID: 35953029 Free article.
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.
Longval T, Leprêtre AC, Ravinet A, Fayard A, Forcade E, Coman T, Redjoul R, Berceanu A, Buchbinder N, Berlie G, Mappoura M, Giannotti F, Chevillon F, Robin M, Peffault de Latour R, Sicre de Fontbrune F; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Longval T, et al. Among authors: mappoura m. Bone Marrow Transplant. 2024 Mar 9. doi: 10.1038/s41409-024-02202-9. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38461290 No abstract available.
Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant.
Courjon J, Portillo V, Yerly S, Vetter P, Schibler M, Mappoura M, Morin S, Giannotti F, Mamez AC, van Delden C, Kaiser L, Chalandon Y, Masouridi-Levrat S, Neofytos D. Courjon J, et al. Among authors: mappoura m. Open Forum Infect Dis. 2023 Nov 24;10(12):ofad595. doi: 10.1093/ofid/ofad595. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38094666 Free PMC article.